These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15068992)

  • 1. Itraconazole versus fluconazole for antifungal prophylaxis.
    Powers JH; Higgins KM
    Ann Intern Med; 2004 Apr; 140(7):580; author reply 581-2. PubMed ID: 15068992
    [No Abstract]   [Full Text] [Related]  

  • 2. Itraconazole versus fluconazole for antifungal prophylaxis.
    Mossad SB
    Ann Intern Med; 2004 Apr; 140(7):580-1; author reply 581-2. PubMed ID: 15068993
    [No Abstract]   [Full Text] [Related]  

  • 3. Itraconazole versus fluconazole for antifungal prophylaxis.
    Karthaus M; Cornely OA; Ullmann AJ
    Ann Intern Med; 2004 Apr; 140(7):579-80; author reply 581-2. PubMed ID: 15068991
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
    Mossad SB; Avery RK; Bolwell BJ
    Clin Infect Dis; 2003 Jun; 36(11):1503-4; author reply 1504. PubMed ID: 12766853
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ; Michalopoulos A; Falagas ME
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation.
    Marr KA
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S170-5. PubMed ID: 15546113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
    Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS; Back H; Kang S; Lee EK
    Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
    Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
    Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
    van Burik JA
    Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing a study population for the evaluation of antifungal prophylaxis.
    Cornely OA; Ullmann AJ; Karthaus M
    Clin Infect Dis; 2005 Jun; 40(11):1699; author reply 1699-701. PubMed ID: 15889374
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
    Huijgens PC; Simoons-Smit AM; van Loenen AC; Prooy E; van Tinteren H; Ossenkoppele GJ; Jonkhoff AR
    J Clin Pathol; 1999 May; 52(5):376-80. PubMed ID: 10560360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation].
    Ota S; Wada A; Kosugi M; Matsuoka S; Asanuma S; Fujii S; Noguchi S; Nakata M; Imai K; Hirano T; Kobayashi N; Ogasawara M; Kiyama Y; Kasai M
    Rinsho Ketsueki; 2010 Jan; 51(1):63-8. PubMed ID: 20134142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inadequate references in recent article.
    de la Cámara R; Jarque I; Grau S; Carreras E
    Am J Health Syst Pharm; 2012 Jun; 69(11):917-22; author reply 922. PubMed ID: 22610019
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current Status and Future Perspectives of Primary Antifungal Prophylaxis in Patients with Hematological Malignancies-Review].
    Li Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):627-632. PubMed ID: 28446325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.